Clinical Trial Update: Study to Assess Efficacy and Safety of Inecalcitol in Imatinib-Treated Residual Chronic Myeloid Leukaemia: INIM Study [Phase 2]

View source ↗

Summary

A Phase 2 study to assess the efficacy and safety of ineCalcitol added to imatinib in patients with chronic-phase chronic myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)
• Inecalcitol (inecalcitol)

Snippet

Sponsor: Hybrigenics Corporation | Conditions: CML, Chronic Phase | Phase 2 | Status: UNKNOWN